A Comparison of Platelet Inhibition Following a Prasugrel 60 mg or Prasugrel 30 mg Loading Dose With or Without Pretreatment With a Clopidogrel Loading Dose in Acute Coronary Syndrome Patients Who Are to Undergo Percutaneous Coronary Intervention.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Embolism and thrombosis; Myocardial infarction; Unstable angina pectoris
- Focus Pharmacodynamics
- Acronyms TRIPLET
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 09 May 2012 Official Title amended as reported by Clinical Trials Registry - India record.
- 19 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History